ondasdechoque.org
PT-BR

Myofascial pain syndrome: multiple sites · Review · 2023

How does shockwave fit among physical treatments for myofascial pain?

This review of 25 trials looked at ten physical treatments for myofascial (muscle knot) pain. Across the six shockwave trials, pain and disability measures improved. Of those comparing shockwave with another treatment, one against dry needling found no clear difference; the others favoured shockwave on some measures.

randomized trials
25
kinds of physical treatment compared
10
trials that tested shockwave
6

Good to know: The trials were too varied to combine into one result, and shockwave settings differed from trial to trial.

He P, Fu W, Shao H, et al. BMC Musculoskeletal Disorders, 2023 · Read the paper ↗

How this study worked

One answer
A review gathers earlier studies to answer one question. Illustration, not to scale.

What the trials used

ESWT summary
Across included studies: reported energy-flux density 0.056–0.26 mJ/mm², 1,000–2,500 pulses and 2–15 sessions; individual protocols differ. The minimum session count and maximum energy come from distinct Table 1 studies. The review's text summary gives 0.056–0.25 mJ/mm² and 3–15 sessions instead, which does not match these two Table 1 rows (Ömer Gezginaslan 2020, 0.26 mJ/mm²; Park 2018, 2 sessions).
TENS summary
Reported frequency 5–100 Hz, pulse width 80 μs–100 ms, 10–30 minutes and 5–12 sessions (the review's text summary; Table 1 lists 120 Hz for conventional TENS in Ebadi 2021).
Ultrasound summary
Reported frequency 1–3 MHz, intensity 1–1.5 W/cm² and 10–15 sessions.

Who took part

People with myofascial pain at many different body sites, across 25 trials; the review gives no single total.

Side effects

The review says no side effects were reported.

All the numbers and the full appraisal
FROM THE FULL PAPER

What the full paper reports.

25 randomized studies of people with myofascial pain syndrome (mostly adults; two trials' age ranges start at 16 years) across multiple anatomical sites and ten physical modalities.

ESWT for myofascial pain1 reported outcome
01
After treatment; timing varied by trial

ESWT for myofascial pain

VAS, NDI, SF-36, PPT Qualitative synthesis; no pooled numeric estimate reported

Six studies reported within-arm VAS and NDI reductions; five compared ESWT with another treatment. One comparison, with dry needling (Table 1; the review's text calls it acupuncture), found no significant difference; other trials favored ESWT on selected outcomes. No pooled estimate was possible.

Analysis details and source

Review-level narrative; do not infer a common effect size across heterogeneous modalities and trials. The review's text says VAS and NDI fell in all six ESWT studies, but Table 1 lists neither VAS nor NDI for Király 2018 (its outcomes are PPT, SF-36, a 4-grade Likert scale and NFI).

Laser for myofascial pain1 reported outcome
02
Post-treatment; 1–15 sessions

Laser for myofascial pain

Pain, PPT, NDI, SF-36 Qualitative synthesis; no pooled numeric estimate reported

Four studies included sham controls. Results varied by laser type and comparator; some between-group benefits were reported, but the review did not pool effects.

Analysis details and source

Review-level narrative; do not infer a common effect size across heterogeneous modalities and trials. The review's text says all four laser studies used a sham-laser control, but Table 1 shows no sham arm for Sumen 2015 (LLLT plus stretching, intramuscular electrical stimulation plus stretching, stretching alone).

TENS for myofascial pain1 reported outcome
03
Immediate through 3 months, depending on trial

TENS for myofascial pain

Pain, PPT, neck ROM, function Qualitative synthesis; no pooled numeric estimate reported

Four upper-trapezius studies reported improvement in some pain or ROM outcomes; AL-TENS and conventional TENS both improved measures in one trial, while only AL-TENS improved lateral-flexion ROM. The review reports selected head-to-head advantages, not pooled estimates.

Analysis details and source

Review-level narrative; do not infer a common effect size across heterogeneous modalities and trials.

Ultrasound for myofascial pain1 reported outcome
04
After 10–15 sessions

Ultrasound for myofascial pain

Pain, PPT Qualitative synthesis; no pooled numeric estimate reported

Three studies used sham ultrasound controls; two reported between-group differences, and continuous ultrasound was reported as better than pulsed ultrasound for resting pain in one comparison.

Analysis details and source

Review-level narrative; do not infer a common effect size across heterogeneous modalities and trials.

tDCS for myofascial pain1 reported outcome
05
After five 20-minute sessions

tDCS for myofascial pain

Pain Qualitative synthesis; no pooled numeric estimate reported

Two studies reported within-group pain reductions but no significant active-versus-sham difference; one study favored dorsolateral prefrontal over M1 stimulation.

Analysis details and source

Review-level narrative; do not infer a common effect size across heterogeneous modalities and trials. The Discussion says the significant between-group pain difference in Sakrajai et al. disappeared in the second week of follow-up, which conflicts with this section's statement that pain did not change significantly versus sham in either study.

Biofeedback1 reported outcome
06
After 6–14 sessions

Biofeedback

Pain, muscle function, NDI, neck ROM Qualitative synthesis; no pooled numeric estimate reported

Two studies reported improvements, but neither included a sham control; these findings do not isolate the specific treatment effect.

Analysis details and source

Review-level narrative; do not infer a common effect size across heterogeneous modalities and trials.

Cervical traction1 reported outcome
07
Immediately and 1 year

Cervical traction

PPT, neck ROM, NRS, NDI Qualitative synthesis; no pooled numeric estimate reported

One study reported between-group differences in PPT and ROM and differences in NRS, NDI, PPT and ROM immediately and at one year; a single trial cannot establish broad effectiveness.

Analysis details and source

Review-level narrative; do not infer a common effect size across heterogeneous modalities and trials. Table 1 is more specific: NDI and NRS improved equally in both groups at 10 weeks, with between-group differences favoring traction for PPT, sagittal alignment and all neck ROM measures; all variables differed between groups at the 1-year follow-up.

TECAR1 reported outcome
08
Immediate post-treatment

TECAR

Skin temperature, lunge test, VAS Qualitative synthesis; no pooled numeric estimate reported

One sham-controlled study (15 intervention, 17 sham) reported higher skin temperature but no between-group difference in lunge test or VAS.

Analysis details and source

Review-level narrative; do not infer a common effect size across heterogeneous modalities and trials.

Safety reporting across modalities1 reported outcome
09
Not consistently specified

Safety reporting across modalities

Adverse effects Qualitative synthesis; no pooled numeric estimate reported

The review states no side effects were reported, but does not establish uniform active harm surveillance across trials; this should not be read as proof of zero risk.

Analysis details and source

Review-level narrative; do not infer a common effect size across heterogeneous modalities and trials.

How treatment was delivered
ESWT summary

Across included studies: reported energy-flux density 0.056–0.26 mJ/mm², 1,000–2,500 pulses and 2–15 sessions; individual protocols differ. The minimum session count and maximum energy come from distinct Table 1 studies. The review's text summary gives 0.056–0.25 mJ/mm² and 3–15 sessions instead, which does not match these two Table 1 rows (Ömer Gezginaslan 2020, 0.26 mJ/mm²; Park 2018, 2 sessions).

TENS summary

Reported frequency 5–100 Hz, pulse width 80 μs–100 ms, 10–30 minutes and 5–12 sessions (the review's text summary; Table 1 lists 120 Hz for conventional TENS in Ebadi 2021).

Ultrasound summary

Reported frequency 1–3 MHz, intensity 1–1.5 W/cm² and 10–15 sessions.

HARMS & TOLERABILITY

Review says no side effects were reported, but consistent active collection was not established; this does not prove zero harms.

LIMITS OF THE ANALYSIS

The evidence mixes modalities, body sites, settings and outcomes. Risk of bias was assessed, and the authors note limitations in protocol consistency; pooled estimates and unified safety ascertainment are absent.

This review is a map of treatment research, not proof that every modality works or that shockwave is superior. Its ESWT section reports favorable signals on selected measures alongside mixed comparator results.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • The evidence mixes modalities, body sites, settings and outcomes. Risk of bias was assessed, and the authors note limitations in protocol consistency; pooled estimates and unified safety ascertainment are absent.
  • This review is a map of treatment research, not proof that every modality works or that shockwave is superior. Its ESWT section reports favorable signals on selected measures alongside mixed comparator results.
Research review

Source-linked critical reading

Systematic clinical review

Reading depthMaterial consulted
Technical source record

Complete article XML read, including Methods, all Results subsections and tables, figure captions, Discussion, Conclusion and disclosures.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design and evidence base

Systematic review of randomized trials. The search identified 761 records; 25 studies were included across ten modalities. Heterogeneity prevented planned meta-analysis.

Participants

Participants had myofascial pain syndrome at varied sites and differed across trials. The review does not provide a single independent participant total in the narrative summary.

Intervention

The review covers ESWT, laser, TENS, ultrasound, tDCS, biofeedback, traction, far-infrared, TECAR and whirlpool; shockwave settings vary substantially (the text reports 0.056–0.25 mJ/mm², 1,000–2,500 pulses and 3–15 sessions, while Table 1 lists up to 0.26 mJ/mm² and as few as 2 sessions).

Comparator

Trial comparators included sham, usual care, exercise, other physical modalities and active treatments; no single pooled comparison applies across the review.

Outcomes

Selected studies report improvements in pain, range of motion, pressure threshold or quality-of-life domains, but this narrative review does not provide pooled effect estimates. ESWT-specific results are mixed by comparator and outcome.

Between-group interpretation

No meta-analysis was possible because of heterogeneity. A nonsignificant between-group result (such as tDCS versus sham, or ESWT versus dry needling, which the review's text calls acupuncture) does not establish equivalence.

Harms

The authors state no side effects were reported; consistent prospective adverse-event surveillance is not established across included studies.

Limitations

The evidence mixes modalities, body sites, settings and outcomes. Risk of bias was assessed, and the authors note limitations in protocol consistency; pooled estimates and unified safety ascertainment are absent.

Applicability

This review is a map of treatment research, not proof that every modality works or that shockwave is superior. Its ESWT section reports favorable signals on selected measures alongside mixed comparator results.

What a stronger study should do

Trials should prespecify one patient-important primary outcome, use adequate allocation and blinded assessment where feasible, standardize dose reporting, assess harms actively and report between-group estimates with uncertainty.

THE ORIGINAL SOURCE

Read the original article.

The effect of therapeutic physical modalities on pain, function, and quality of life in patients with myofascial pain syndrome: a systematic review.

He P, Fu W, Shao H, Zhang M, Xie Z, Xiao J, Li L, Liu Y, Cheng Y, Wang Q. · BMC musculoskeletal disorders · 2023

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →